Búsqueda | Portal de Búsqueda de la BVS España

1.

What is the outcome in patients with acute leukaemia who survive severe acute graft-versus-host disease?

Ringdén, O; Labopin, M; Sadeghi, B; Mailhol, A; Beelen, D; Fløisand, Y; Ghavamzadeh, A; Finke, J; Ehninger, G; Volin, L; Socié, G; Kröger, N; Stuhler, G; Ganser, A; Schmid, C; Giebel, S; Mohty, M; Nagler, A.

J Intern Med; 283(2): 166-177, 2018 02.

Artículo en Inglés | MEDLINE | ID: mdl-29027756

2.

Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the CMWP of the EBMT.

Cremers, E M P; van Biezen, A; de Wreede, L C; Scholten, M; Vitek, A; Finke, J; Platzbecker, U; Beelen, D; Schwerdtfeger, R; Volin, L; Harhalakis, N; Blijlevens, N; Nagler, A; Kröger, N; de Witte, T.

Ann Hematol; 95(12): 1971-1978, 2016 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-27650829

3.

Cellular uptake of coumarin-6 under microfluidic conditions into HCE-T cells from nanoscale formulations.

Pretor, S; Bartels, J; Lorenz, T; Dahl, K; Finke, J H; Peterat, G; Krull, R; Al-Halhouli, A T; Dietzel, A; Büttgenbach, S; Behrends, S; Reichl, S; Müller-Goymann, C C.

Mol Pharm; 12(1): 34-45, 2015 Jan 05.

Artículo en Inglés | MEDLINE | ID: mdl-25412253

4.

Outcome and prognostic factors in patients with mantle-cell lymphoma relapsing after autologous stem-cell transplantation: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT).

Dietrich, S; Boumendil, A; Finel, H; Avivi, I; Volin, L; Cornelissen, J; Jarosinska, R J; Schmid, C; Finke, J; Stevens, W B C; Schouten, H C; Kaufmann, M; Sebban, C; Trneny, M; Kobbe, G; Fornecker, L M; Schetelig, J; Kanfer, E; Heinicke, T; Pfreundschuh, M; Diez-Martin, J L; Bordessoule, D; Robinson, S; Dreger, P.

Ann Oncol; 25(5): 1053-8, 2014 May.

Artículo en Inglés | MEDLINE | ID: mdl-24585719

5.

Sequential vs myeloablative vs reduced intensity conditioning for patients with myelodysplastic syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: a retrospective study by the chronic malignancies working party of the EBMT.

Potter, V; Gras, L; Koster, L; Kroger, N; Sockel, K; Ganser, A; Finke, J; Labussiere-Wallet, H; Peffault de Latour, R; Koc, Y; Salmenniemi, U; Smidstrup Friis, L; Jindra, P; Schroeder, T; Tischer, J; Arat, M; Pascual Cascon, M; de Wreede, L C; Hayden, P; Raj, K; Drozd-Sokolowska, J; Scheid, C; McLornan, D P; Robin, M; Yakoub-Agha, I.

Bone Marrow Transplant; 59(2): 224-231, 2024 02.

Artículo en Inglés | MEDLINE | ID: mdl-37993503

6.

In vitro and ex vivo toxicological testing of sildenafil-loaded solid lipid nanoparticles.

Paranjpe, M; Neuhaus, V; Finke, J H; Richter, C; Gothsch, T; Kwade, A; Büttgenbach, S; Braun, A; Müller-Goymann, C C.

Inhal Toxicol; 25(9): 536-43, 2013 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-23905970

7.

Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma--a long-term follow-up study.

Kasenda, B; Schorb, E; Fritsch, K; Finke, J; Illerhaus, G.

Ann Oncol; 23(10): 2670-2675, 2012 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-22473593

8.

Comparing long-term toxicity and efficacy of combined modality treatment including extended- or involved-field radiotherapy in early-stage Hodgkin's lymphoma.

Sasse, S; Klimm, B; Görgen, H; Fuchs, M; Heyden-Honerkamp, A; Lohri, A; Koch, O; Wilhelm, M; Trenn, G; Finke, J; Müller, R P; Diehl, V; Eich, H T; Borchmann, P; Engert, A.

Ann Oncol; 23(11): 2953-2959, 2012 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-22767583

9.

Bone marrow or peripheral blood stem cell transplantation from unrelated donors in adult patients with acute myeloid leukaemia, an Acute Leukaemia Working Party analysis in 2262 patients.

Ringdén, O; Labopin, M; Beelen, D W; Volin, L; Ehninger, G; Finke, J; Greinix, H T; Kyrcz-Krzemien, S; Bunjes, D; Brinch, L; Niederwieser, D; Arnold, R; Mohty, M; Rocha, V.

J Intern Med; 272(5): 472-83, 2012 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-22519980

10.

[Current diagnostics and therapy of B cell Non Hodgkin Lymphoma]. / Aktuelle Diagnostik und Therapie bei B-Zell Non Hodgkin Lymphomen.

Baumgarten, A; Finke, J; Marks, R.

Ther Umsch; 69(10): 571-5, 2012 Oct.

Artículo en Alemán | MEDLINE | ID: mdl-23026882

11.

Comparison of TWA and PEP as indices of α2- and ß-adrenergic activation.

Drost, L; Finke, J B; Port, J; Schächinger, H.

Psychopharmacology (Berl); 239(7): 2277-2288, 2022 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-35394159

12.

Immunochemotherapy with rituximab, methotrexate, procarbazine, and lomustine for primary CNS lymphoma (PCNSL) in the elderly.

Fritsch, K; Kasenda, B; Hader, C; Nikkhah, G; Prinz, M; Haug, V; Haug, S; Ihorst, G; Finke, J; Illerhaus, G.

Ann Oncol; 22(9): 2080-2085, 2011 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-21303800

13.

Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia.

Greil, C; Engelhardt, M; Ihorst, G; Duque-Afonso, J; Shoumariyeh, K; Bertz, H; Marks, R; Zeiser, R; Duyster, J; Finke, J; Wäsch, R.

Bone Marrow Transplant; 56(4): 841-852, 2021 04.

Artículo en Inglés | MEDLINE | ID: mdl-33130821

14.

Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma--a long-term follow-up study.

Kasenda, B; Schorb, E; Fritsch, K; Finke, J; Illerhaus, G.

Ann Oncol; 26(3): 608-11, 2015 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-25725080

15.

Autologous hematopoietic stem cell transplantation for relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the lymphoma working party (LWP) of the EBMT.

Domingo-Domènech, E; Boumendil, A; Climent, F; Sengeloev, H; Wahlin, B; Wattad, W; Arat, M; Finel, H; Schapp, N; Ganser, A; Yeshurun, M; Pavone, V; Snowden, J; Finke, J; Montoto, S; Sureda, A; Dreger, P.

Bone Marrow Transplant; 55(4): 796-803, 2020 04.

Artículo en Inglés | MEDLINE | ID: mdl-31695174

16.

High-dose methotrexate combined with procarbazine and CCNU for primary CNS lymphoma in the elderly: results of a prospective pilot and phase II study.

Illerhaus, G; Marks, R; Müller, F; Ihorst, G; Feuerhake, F; Deckert, M; Ostertag, C; Finke, J.

Ann Oncol; 20(2): 319-25, 2009 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-18953065

17.

Placental mononuclear phagocytes as a source of interleukin-1.

Flynn, A; Finke, J H; Hilfiker, M L.

Science; 218(4571): 475-7, 1982 Oct 29.

Artículo en Inglés | MEDLINE | ID: mdl-6981846

18.

EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL).

Wiktor-Jedrzejczak, W; Drozd-Sokolowska, J; Eikema, D J; Hoek, J; Potter, M; Wulf, G; Sellner, L; Ljungman, P; Chevallier, P; Volin, L; Koc, Y; Martin, S; Bunjes, D; Rovira, M; Itälä-Remes, M; Foá, R; Deconinck, E; Gedde-Dahl, T; Cornelissen, J; Collin, M; Brecht, A; Patel, A; de Groot, M; Reményi, P; Nagler, A; Finke, J; Turlure, P; Iacobelli, S; van Biezen, A; Schetelig, J; Kröger, N; Dreger, P.

Bone Marrow Transplant; 54(9): 1391-1398, 2019 09.

Artículo en Inglés | MEDLINE | ID: mdl-30664723

19.

A fludarabine, thiotepa reduced toxicity conditioning regimen designed specifically for allogeneic second haematopoietic cell transplantation after failure of previous autologous or allogeneic transplantation.

Grüllich, C; Bertz, H; Spyridonidis, A; Müller, C I; Finke, J.

Bone Marrow Transplant; 41(10): 845-50, 2008 May.

Artículo en Inglés | MEDLINE | ID: mdl-18209719

20.

Viewpoint: What is the role of allogeneic haematopoietic cell transplantation in the era of reduced-intensity conditioning--is there still an upper age limit? A focus on myeloid neoplasia.

Finke, J; Nagler, A.

Leukemia; 21(7): 1357-62, 2007 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-17508002

Portal de Búsqueda de la BVS España

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

What is the outcome in patients with acute leukaemia who survive severe acute graft-versus-host disease?

Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the CMWP of the EBMT.

Cellular uptake of coumarin-6 under microfluidic conditions into HCE-T cells from nanoscale formulations.

Outcome and prognostic factors in patients with mantle-cell lymphoma relapsing after autologous stem-cell transplantation: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT).

Sequential vs myeloablative vs reduced intensity conditioning for patients with myelodysplastic syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: a retrospective study by the chronic malignancies working party of the EBMT.

In vitro and ex vivo toxicological testing of sildenafil-loaded solid lipid nanoparticles.

Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma--a long-term follow-up study.

Comparing long-term toxicity and efficacy of combined modality treatment including extended- or involved-field radiotherapy in early-stage Hodgkin's lymphoma.

Bone marrow or peripheral blood stem cell transplantation from unrelated donors in adult patients with acute myeloid leukaemia, an Acute Leukaemia Working Party analysis in 2262 patients.

[Current diagnostics and therapy of B cell Non Hodgkin Lymphoma]. / Aktuelle Diagnostik und Therapie bei B-Zell Non Hodgkin Lymphomen.

Comparison of TWA and PEP as indices of α2- and ß-adrenergic activation.

Immunochemotherapy with rituximab, methotrexate, procarbazine, and lomustine for primary CNS lymphoma (PCNSL) in the elderly.

Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia.

Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma--a long-term follow-up study.

Autologous hematopoietic stem cell transplantation for relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the lymphoma working party (LWP) of the EBMT.

High-dose methotrexate combined with procarbazine and CCNU for primary CNS lymphoma in the elderly: results of a prospective pilot and phase II study.

Placental mononuclear phagocytes as a source of interleukin-1.

EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL).

A fludarabine, thiotepa reduced toxicity conditioning regimen designed specifically for allogeneic second haematopoietic cell transplantation after failure of previous autologous or allogeneic transplantation.

Viewpoint: What is the role of allogeneic haematopoietic cell transplantation in the era of reduced-intensity conditioning--is there still an upper age limit? A focus on myeloid neoplasia.